Astrana Health, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $19.7M | $14.4M | $373.0K | $9.4M | $6.7M | $16.1M | $19.2M | $14.8M |
| Depreciation & Amortization | $15.6M | $15.5M | $15.6M | $6.9M | $6.8M | $7.3M | $7.4M | $5.1M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $13.8M | $13.9M | $14.2M | $6.2M | $6.3M | $6.7M | $6.9M | $6.9M |
| Stock-Based Compensation | — | $9.9M | — | — | $7.8M | — | — | $5.7M |
| Net Cash from Operating Activities | $32.7M | $68.1M | $10.0M | $90.9M | $16.6M | $34.0M | $23.2M | $6.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.9M | $4.0M | $2.6M | $1.4M | $3.1M | $2.3M | $2.8M | $369.0K |
| Business Acquisitions | — | — | — | — | $0 | — | — | $50.6M |
| Net Cash from Investing Activities | — | $-2.8M | — | — | $-2.4M | — | — | $-71.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | $104.0K | — | — | $5.5M | — | — | $95.0K |
| Stock Repurchases | — | $2.8M | — | — | $10.6M | — | — | — |
| Net Cash from Financing Activities | — | $-16.0M | — | — | $-44.2M | — | — | $106.4M |
| Net Change in Cash | — | $49.3M | — | — | $-29.9M | — | — | $41.3M |
| Free Cash Flow | $28.9M | $64.1M | $7.4M | $89.5M | $13.6M | $31.7M | $20.4M | $5.6M |